US EditionEnliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Sells $52,585.00 in Stock
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Enliven Therapeutics, Inc. (NASDAQ:ELVN) CFO Sells $52,585.00 in Stock
Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) CFO Benjamin Hohl sold 3,250 shares of the stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $16.18, for a total value of $52,585.00. Following the sale, the chief financial officer now directly owns 23,000 shares in the company, […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
